Drugs acting on the respiratory system

2017-07-30T05:10:08+03:00[Europe/Moscow] en true Dornase alfa, Fluticasone, Pirfenidone, Lucinactant, Guacetisal, Denufosol, Poractant alfa, Guaifenesin/phenylephrine, Fluticasone propionate, Fluticasone furoate/vilanterol, Umeclidinium bromide, Umeclidinium bromide/vilanterol flashcards Drugs acting on the respiratory system
Click to flip
  • Dornase alfa
    Dornase alfa (proprietary name Pulmozyme from Genentech) is a highly purified solution of recombinant human deoxyribonuclease I (rhDNase), an enzyme which selectively cleaves DNA.
  • Fluticasone
    Fluticasone is a synthetic glucocorticoid.
  • Pirfenidone
    Pirfenidone (INN, BAN) is an anti-fibrotic drug for the treatment of idiopathic pulmonary fibrosis (IPF).
  • Lucinactant
    Lucinactant (trade name Surfaxin) is a liquid medication used to treat infant respiratory distress syndrome.
  • Guacetisal
    Guacetisal is a drug that has been used to treat inflammatory respiratory diseases.
  • Denufosol
    Denufosol (INN) is an inhaled drug for the treatment of cystic fibrosis, being developed by Inspire Pharmaceuticals and sponsored by the Cystic Fibrosis Foundation.
  • Poractant alfa
    Poractant alfa is a pulmonary surfactant sold under the brand name Curosurf by Chiesi Farmaceutici.
  • Guaifenesin/phenylephrine
    The combination of the drugs guaifenesin and phenylephrine is a preparation against the symptoms of cold, flu and allergy.
  • Fluticasone propionate
    Fluticasone propionate belongs to a class of drugs known as corticosteroids, specifically glucocorticoids, which are hormones that predominantly affect the metabolism of carbohydrates and, to a lesser extent, fat and protein.
  • Fluticasone furoate/vilanterol
    Fluticasone furoate/vilanterol (trade names Breo Ellipta and Relvar Ellipta) is a combination drug for the treatment of chronic obstructive pulmonary disease (COPD) and asthma.
  • Umeclidinium bromide
    Umeclidinium bromide (trade name Incruse Ellipta, GSK) is a long-acting muscarinic antagonist approved for the maintenance treatment of chronic obstructive pulmonary disease (COPD).
  • Umeclidinium bromide/vilanterol
    Umeclidinium bromide/vilanterol (trade name Anoro Ellipta) is a combination drug approved for the treatment of chronic obstructive pulmonary disease (COPD).